One-Year Real-World Glycemic and Quality-of-Life Outcomes of the t:slim X2 Insulin Pump with Control-IQ technology
Join Marc Breton, PhD from the University of Virginia and Steph Habif, EdD MS with Tandem Diabetes Care, to learn more about data published by Diabetes Technology and Therapeutics (DTT)on the latest real-world results on one year use of the t:slim X2™ insulin pump with Control-IQ® technology. Dr. Breton will discuss one-year real-world study results from 9,451 Control-IQ technology users, and Dr.Habif will cover quality-of-life outcomes and glycemic control from the ongoing Control-IQ Observational (CLIO) Study of 700 participants, which aims to evaluate real-world use of the t:slim X2 insulin pump with Control-IQ technology in diverse groups of people with type 1 diabetes.
One-Year Real-World Glycemic and Quality-of-Life Outcomes of
the t:slim X2 Insulin Pump with Control-IQ technology
* Tandem Diabetes Care will have an exhibit table at each event, but Tandem is not the event organizer and does not have control of the information shared outside of its exhibit space.